2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk
作者: Lisandro D. ColantonioJohn N. BoothAdam P. BressPaul K. WheltonDaichi ShimboEmily B. LevitanGeorge HowardMonika M. SaffordPaul Muntner
作者单位: 1Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama
2Department of Population Health Sciences, University of Utah, Salt Lake City, Utah
3Department of Epidemiology, Tulane University, New Orleans, Louisiana
4Department of Medicine, Columbia University, New York, New York
5Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama
6Department of Medicine, Weill Cornell Medical College, New York, New York
刊名: Journal of the American College of Cardiology, 2018, Vol.72 (11), pp.1187-1197
来源数据库: Elsevier Journal
DOI: 10.1016/j.jacc.2018.05.074
关键词: AdultAntihypertensive agentsBlood pressureCardiovascular diseaseHypertensionPractice guidelines
英文摘要: Abstract(#br)Background(#br)The 2017 American College of Cardiology/American Heart Association (ACC/AHA) blood pressure (BP) guideline provides updated recommendations for antihypertensive medication initiation and intensification.(#br)Objectives(#br)Determine the risk for cardiovascular disease (CVD) events among adults recommended and not recommended antihypertensive medication initiation or intensification by the 2017 ACC/AHA BP guideline.(#br)Methods(#br)The authors analyzed data for black and white REGARDS (REasons for Geographic And Racial Differences in Stroke) study participants (age ≥45 years). Systolic BP (SBP) and diastolic BP (DBP) were measured twice at baseline (2003 to 2007) and averaged. Participants not taking (n = 14,039) and taking (n = 15,179) antihypertensive...
全文获取路径: Elsevier  (合作)
影响因子:14.086 (2012)

  • Blood 
  • ACC accumulate